Alnylam Pharmaceuticals Inc (ALNY.OQ)

ALNY.OQ on NASDAQ Stock Exchange Global Select Market

97.92USD
26 Dec 2014
Price Change (% chg)

$4.40 (+4.70%)
Prev Close
$93.52
Open
$93.63
Day's High
$98.82
Day's Low
$93.63
Volume
93,282
Avg. Vol
250,405
52-wk High
$112.40
52-wk Low
$47.03

ALNY.OQ

Chart for ALNY.OQ

About

Alnylam Pharmaceuticals, Inc. (Alnylam) is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). Its Alnylam 5x15, is focused on the development and commercialization of novel RNAi therapeutics for the treatment of genetically defined diseases. Its core programs in clinical or pre-clinic... (more)

Overall

Beta: 1.66
Market Cap (Mil.): $7,533.09
Shares Outstanding (Mil.): 76.93
Dividend: --
Yield (%): --

Financials

  ALNY.OQ Industry Sector
P/E (TTM): -- 159.35 38.84
EPS (TTM): -5.37 -- --
ROI: -56.18 -0.82 18.26
ROE: -61.79 -1.98 19.12
Search Stocks

Earnings vs. Estimates

Search Stocks